Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 11 2022
Historique:
received: 23 03 2022
accepted: 19 10 2022
pubmed: 6 11 2022
medline: 9 11 2022
entrez: 6 11 2022
Statut: epublish

Résumé

Lymphocystis disease virus-1 (LCDV-1) and several other Iridoviridae encode viral insulin/IGF-1 like peptides (VILPs) with high homology to human insulin and IGFs. Here we show that while single-chain (sc) and double-chain (dc) LCDV1-VILPs have very low affinity for the insulin receptor, scLCDV1-VILP has high affinity for IGF1R where it can antagonize human IGF-1 signaling, without altering insulin signaling. Consequently, scLCDV1-VILP inhibits IGF-1 induced cell proliferation and growth hormone/IGF-1 induced growth of mice in vivo. Cryo-electron microscopy reveals that scLCDV1-VILP engages IGF1R in a unique manner, inducing changes in IGF1R conformation that led to separation, rather than juxtaposition, of the transmembrane segments and hence inactivation of the receptor. Thus, scLCDV1-VILP is a natural peptide with specific antagonist properties on IGF1R signaling and may provide a new tool to guide development of hormonal analogues to treat cancers or metabolic disorders sensitive to IGF-1 without affecting glucose metabolism.

Identifiants

pubmed: 36335114
doi: 10.1038/s41467-022-34391-6
pii: 10.1038/s41467-022-34391-6
pmc: PMC9637144
doi:

Substances chimiques

Receptor, IGF Type 1 EC 2.7.10.1
Insulin-Like Growth Factor I 67763-96-6
Insulin 0
Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6700

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK036836
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK031036
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK031036
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK117967
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Structure. 2020 Jul 7;28(7):786-798.e6
pubmed: 32459985
Drug Des Devel Ther. 2018 Sep 11;12:2887-2896
pubmed: 30254418
Mol Endocrinol. 1999 Dec;13(12):2163-74
pubmed: 10598589
J Gen Virol. 2017 May;98(5):890-891
pubmed: 28555546
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2461-2466
pubmed: 29467286
Mol Cell Biol. 1999 May;19(5):3278-88
pubmed: 10207053
Genomics. 1999 Aug 15;60(1):50-6
pubmed: 10458910
J Clin Invest. 1990 May;85(5):1672-9
pubmed: 2159026
Protein Eng. 1996 Nov;9(11):1011-9
pubmed: 8961354
J Histochem Cytochem. 1995 Jan;43(1):11-9
pubmed: 7822759
Biol Chem. 2003 May;384(5):805-9
pubmed: 12817477
Target Oncol. 2017 Oct;12(5):571-597
pubmed: 28815409
J Biol Chem. 1992 Jul 25;267(21):15229-36
pubmed: 1634553
Science. 1982 Jan 8;215(4529):185-7
pubmed: 7031900
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Physiol Rev. 2013 Jan;93(1):405-80
pubmed: 23303914
Mol Cell Endocrinol. 2020 Dec 1;518:111035
pubmed: 32941924
Science. 1991 Oct 25;254(5031):539-44
pubmed: 1948029
Mol Metab. 2021 Feb;44:101121
pubmed: 33220491
J Biol Chem. 2002 Oct 18;277(42):39684-95
pubmed: 12138094
Res Microbiol. 2008 Jun;159(5):367-73
pubmed: 18541415
Can Med Assoc J. 1962 Nov 17;87:1046-51
pubmed: 13967778
Gene Ther. 2010 Apr;17(4):503-10
pubmed: 19956269
J Biol Chem. 2008 Jul 25;283(30):20821-9
pubmed: 18502759
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
J Biol Chem. 1994 Apr 8;269(14):10609-13
pubmed: 8144650
J Biol Chem. 1978 Apr 25;253(8):2769-76
pubmed: 632300
Elife. 2014 Sep 25;3:
pubmed: 25255214
Diabetologia. 2010 Aug;53(8):1743-53
pubmed: 20424816
Biochemistry. 1981 Dec 22;20(26):7345-50
pubmed: 6275879
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Biochem J. 2000 May 1;347 Pt 3:771-9
pubmed: 10769182
FEBS Lett. 1978 May 15;89(2):283-6
pubmed: 658418
J Biol Chem. 2016 Jul 8;291(28):14628-38
pubmed: 27226630
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7137-41
pubmed: 6938960
N Engl J Med. 1979 Nov 22;301(21):1138-42
pubmed: 492275
Pediatr Diabetes. 2000 Sep;1(3):169-77
pubmed: 15016228
Eur J Biochem. 1990 Jan 12;187(1):249-54
pubmed: 1688797
Nat Commun. 2017 Mar 27;8:14892
pubmed: 28345670
Cancer Biol Ther. 2003 Nov-Dec;2(6):630-5
pubmed: 14688466
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Eur Thyroid J. 2020 Dec;9(Suppl 1):59-65
pubmed: 33511086
Mol Metab. 2021 Nov;53:101316
pubmed: 34400347
Cell. 2015 Jan 29;160(3):447-60
pubmed: 25619688
J Biol Chem. 2002 Jan 11;277(2):1148-57
pubmed: 11689565
Vitam Horm. 2009;80:1-31
pubmed: 19251032
Genomics. 1995 Sep 20;29(2):465-70
pubmed: 8666396
Nat Commun. 2018 Oct 24;9(1):4420
pubmed: 30356040
Oncogene. 2012 May 31;31(22):2703-14
pubmed: 21963847
Gastroenterology. 2021 Oct;161(4):1257-1269.e13
pubmed: 34175280
Protein Eng. 2001 Jan;14(1):61-5
pubmed: 11287679
Oncotarget. 2017 Apr 25;8(17):29501-29518
pubmed: 28427155
PLoS One. 2014 Aug 18;9(8):e105221
pubmed: 25133738
Endocrinology. 2003 Sep;144(9):3799-810
pubmed: 12933651
Growth Horm IGF Res. 2004 Aug;14(4):309-18
pubmed: 15231300
J Mol Biol. 2009 Dec 18;394(5):878-92
pubmed: 19835884
Commun Biol. 2019 Jun 19;2:218
pubmed: 31240256
Transgenic Res. 2011 Dec;20(6):1305-20
pubmed: 21365322
Proc Natl Acad Sci U S A. 1989 Jan;86(1):114-8
pubmed: 2911561
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31727777
Nat Commun. 2019 Oct 8;10(1):4567
pubmed: 31594955
Endocrinology. 2009 Mar;150(3):1353-60
pubmed: 18948397
FEBS Lett. 2000 Aug 11;479(1-2):15-8
pubmed: 10940380
Nat Commun. 2018 Feb 26;9(1):821
pubmed: 29483580
Biol Reprod. 2000 Jun;62(6):1593-9
pubmed: 10819760
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Francois Moreau (F)

Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.

Nicholas S Kirk (NS)

WEHI, Parkville, VIC, Australia.
Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.

Fa Zhang (F)

Department of Chemistry, Indiana University, Bloomington, IN, USA.

Vasily Gelfanov (V)

Novo Nordisk, Indianapolis Research Center, Indianapolis, USA.

Edward O List (EO)

Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Martina Chrudinová (M)

Boston College Biology Department, Chestnut Hill, MA, USA.

Hari Venugopal (H)

Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Clayton, VIC, Australia.

Michael C Lawrence (MC)

WEHI, Parkville, VIC, Australia.
Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.

Veronica Jimenez (V)

Department of Biochemistry and Molecular Biology, School of Veterinary Medicine and Center of Animal Biotechnology and Gene Therapy, Universitat Autonoma de Barcelona, Bellaterra, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029, Madrid, Spain.

Fatima Bosch (F)

Department of Biochemistry and Molecular Biology, School of Veterinary Medicine and Center of Animal Biotechnology and Gene Therapy, Universitat Autonoma de Barcelona, Bellaterra, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029, Madrid, Spain.

John J Kopchick (JJ)

Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Richard D DiMarchi (RD)

Department of Chemistry, Indiana University, Bloomington, IN, USA.

Emrah Altindis (E)

Boston College Biology Department, Chestnut Hill, MA, USA.

C Ronald Kahn (CR)

Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. c.ronald.kahn@joslin.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH